Royce & Associates LP Collegium Pharmaceutical, Inc Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

A detailed history of Royce & Associates LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Royce & Associates LP holds 305,855 shares of COLL stock, worth $8.92 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
305,855
Previous 300,889 1.65%
Holding current value
$8.92 Million
Previous $9.69 Million 21.99%
% of portfolio
0.11%
Previous 0.09%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$31.4 - $39.07 $155,932 - $194,021
4,966 Added 1.65%
305,855 $11.8 Million
Q2 2024

Aug 13, 2024
BUY
$31.36 - $39.99 $381,964 - $487,078
12,180 Added 4.22%
300,889 $9.69 Million
Q1 2024

May 13, 2024
BUY
$31.23 - $40.91 $4.55 Million - $5.96 Million
145,626 Added 101.78%
288,709 $11.2 Million
Q4 2023

Feb 12, 2024
BUY
$21.16 - $30.8 $2.58 Million - $3.75 Million
121,853 Added 573.97%
143,083 $4.4 Million
Q3 2023

Nov 09, 2023
BUY
$21.23 - $24.28 $450,712 - $515,464
21,230 New
21,230 $474,000
Q4 2022

May 23, 2023
BUY
$16.14 - $23.55 $233,658 - $340,933
14,477 New
14,477 $335,000
Q4 2022

Feb 13, 2023
SELL
$16.14 - $23.55 $223,426 - $326,002
-13,843 Reduced 48.88%
14,477 $336,000
Q3 2022

Nov 03, 2022
SELL
$15.46 - $20.1 $6.68 Million - $8.68 Million
-431,923 Reduced 93.85%
28,320 $454,000
Q2 2022

Aug 04, 2022
BUY
$14.22 - $20.88 $2.4 Million - $3.53 Million
168,989 Added 58.02%
460,243 $8.16 Million
Q1 2022

May 05, 2022
SELL
$17.2 - $22.5 $561,270 - $734,220
-32,632 Reduced 10.08%
291,254 $5.93 Million
Q4 2021

Feb 07, 2022
BUY
$17.5 - $21.35 $2.6 Million - $3.17 Million
148,377 Added 84.54%
323,886 $6.05 Million
Q3 2021

Nov 10, 2021
BUY
$17.75 - $25.39 $3.12 Million - $4.46 Million
175,509 New
175,509 $3.47 Million
Q1 2020

May 12, 2020
SELL
$13.89 - $25.45 $19,737 - $36,164
-1,421 Closed
0 $0
Q4 2019

Feb 06, 2020
SELL
$10.7 - $22.24 $11,342 - $23,574
-1,060 Reduced 42.72%
1,421 $29,000
Q3 2019

Nov 13, 2019
BUY
$10.16 - $13.28 $10,292 - $13,452
1,013 Added 69.01%
2,481 $28,000
Q2 2019

Aug 12, 2019
BUY
$10.62 - $16.59 $3,961 - $6,188
373 Added 34.06%
1,468 $19,000
Q1 2019

May 09, 2019
BUY
$13.58 - $18.72 $14,870 - $20,498
1,095 New
1,095 $17,000
Q3 2018

Nov 13, 2018
SELL
$14.16 - $24.3 $1.95 Million - $3.35 Million
-138,000 Closed
0 $0
Q2 2018

Aug 09, 2018
SELL
$21.79 - $28.29 $697,280 - $905,280
-32,000 Reduced 18.82%
138,000 $3.29 Million
Q1 2018

May 14, 2018
BUY
$18.15 - $29.21 $598,950 - $963,930
33,000 Added 24.09%
170,000 $4.34 Million
Q4 2017

Feb 09, 2018
BUY
$9.3 - $19.14 $1.27 Million - $2.62 Million
137,000
137,000 $2.53 Million

Others Institutions Holding COLL

# of Institutions
255
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $995M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email